PRDX3 promotes resistance to cisplatin in gastric cancer cells

Conclusion: PRDX3 increases the gastric cancer cell resistance to cisplatin by reducing apoptosis and thus may serve as a target to overcome cisplatin resistance.

Source: Journal of Cancer Research and Therapeutics - January 11, 2023 Category: Cancer & Oncology Authors: Hao Yan Xinyu Cai Shanshan Fu Xiubin Zhang Jianna Zhang Source Type: research